Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.184
+0.014 (8.24%)
Mar 9, 2026, 2:25 PM HKT
-0.54%
Market Cap 374.05M
Revenue (ttm) 2.73B
Net Income (ttm) 46.64M
Shares Out 2.03B
EPS (ttm) 0.02
PE Ratio 8.29
Forward PE n/a
Dividend 0.00 (1.18%)
Ex-Dividend Date May 19, 2025
Volume 392,000
Average Volume 122,800
Open 0.175
Previous Close 0.170
Day's Range 0.175 - 0.184
52-Week Range 0.150 - 0.280
Beta 1.22
RSI 63.95
Earnings Date Mar 27, 2026

About HKG:6833

Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. The company offers Octapharma, a human albumin solution for use in premature infants; Axetine, which is used for the treatment of bacterial infections, including respiratory infections, urinary tract infections, soft tissue infections, gynecological and obstetrical infections, gonorrhea, and other infections, as well as for the prevention of post-... [Read more]

Sector Healthcare
Founded 2011
Employees 268
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6833
Full Company Profile

Financial Performance

In 2024, HKG:6833's revenue was 2.82 billion, an increase of 11.07% compared to the previous year's 2.54 billion. Earnings were 42.05 million, a decrease of -0.72%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.